Published in Infect Immun on August 01, 1985
Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest (1994) 1.85
Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice. Infect Immun (1995) 1.57
Deleterious effects of purulent sputum sol on human ciliary function in vitro: at least two factors identified. Thorax (1987) 1.39
The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect Immun (2004) 1.21
Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect Immun (1989) 1.06
Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect Immun (1986) 1.01
Age-dependent pulmonary clearance of Pseudomonas aeruginosa in a mouse model: diminished migration of polymorphonuclear leukocytes to N-formyl-methionyl-leucyl-phenylalanine. Infect Immun (1992) 0.94
Preliminary characterization of Pseudomonas aeruginosa peptide chemotactins for polymorphonuclear leukocytes. Infect Immun (1992) 0.93
Replication rate of Pseudomonas aeruginosa in the murine lung. Infect Immun (1985) 0.79
Acetylornithinase of Escherichia coli: partial purification and some properties. J Biol Chem (1956) 93.84
Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science (1983) 9.51
An apparatus for the study of airborne infection. J Hyg (Lond) (1952) 7.10
Cystic fibrosis. Am Rev Respir Dis (1976) 6.62
A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods (1980) 6.44
Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol (1978) 6.04
Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol (1968) 5.77
The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol (1975) 3.50
Rapid quantitation of neutrophil chemotaxis: use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly. J Immunol Methods (1980) 3.12
Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S. Infect Immun (1984) 3.01
Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun (1982) 2.76
Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis (1983) 2.63
Pseudomonas colonization in cystic fibrosis. A study of 160 patients. JAMA (1978) 2.42
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med (1984) 2.30
Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis (1984) 2.02
Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. Am Rev Respir Dis (1978) 1.97
Phagocyte strategy vs. microbial tactics. Rev Infect Dis (1983) 1.96
Genetic defect in secretion of complement C5 in mice. Nature (1979) 1.68
Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis (1984) 1.64
New aspects of chemotaxis. Specific target-cell attraction by lipid and lipoprotein fractions of Escherichia coli chemotactic factor. Am J Pathol (1975) 1.45
Effects of staphylococcal products on locomotion and chemotaxis of human blood neutrophils and monocytes. J Med Microbiol (1976) 1.27
Pseudomonas aeruginosa exoproducts as pulmonary virulence factors. Can J Microbiol (1983) 1.23
Leukocyte locomotion and chemotaxis: effects of bacteria and viruses. Rev Infect Dis (1980) 1.18
Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant. Infect Immun (1983) 1.14
Isolation and partial characterization of a staphylococcal leukocyte cytotaxin. J Bacteriol (1969) 1.12
The production and characterisation of products of the lipoxygenase enzyme system released by rat peritoneal macrophages. Prostaglandins (1980) 1.09
The injurious effect of neutrophils on pneumocytes in vitro. Am Rev Respir Dis (1984) 1.08
Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung. Eur J Respir Dis (1985) 1.03
Temperature-sensitive mutants of Pseudomonas aeruginosa: isolation and preliminary immunological evaluation. Infect Immun (1982) 1.00
Mechanisms of complement-mediated clearance of bacteria from the murine lung. Am Rev Respir Dis (1982) 0.98
Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B. J Clin Invest (1975) 0.94
Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment. Acta Paediatr Scand (1983) 0.93
Granulocyte-dependent injury of pulmonary endothelium: a case of miscommunication? Tissue Cell (1984) 0.92
Pulmonary cell response to bacterial challenge in mutant mice with some hereditary alterations resembling cystic fibrosis. Life Sci (1980) 0.87
Proteases and lung injury. A state-of-the-art minireview. Chest (1983) 0.86
Oxygen radicals and lung injury. The state of the art. Chest (1983) 0.81
Macrophage effector function in pulmonary oxygen toxicity: hyperoxia damages and stimulates alveolar macrophages to make and release chemotaxins for polymorphonuclear leukocytes. J Leukoc Biol (1984) 0.80
Pulmonary macrophages: when do they prevent and when do they cause COPD? Chest (1980) 0.78
Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med (1966) 5.97
Congenital rubella. Clinicopathologic, virologic, and immunologic studies. Am J Dis Child (1965) 2.82
Pseudomonas colonization in cystic fibrosis. A study of 160 patients. JAMA (1978) 2.42
Impaired in vitro cell-mediated immunity to rubella virus during pregnancy. N Engl J Med (1973) 2.06
A 51 Cr microassay technique for cell-mediated immunity to viruses. J Immunol (1973) 1.91
Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines. J Immunol (1967) 1.79
Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection. Proc Soc Exp Biol Med (1969) 1.79
Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol (1999) 1.69
Role of food allergy in serous otitis media. Ann Allergy (1994) 1.40
Familial thymic aplasia. Attempted reconstitution with fetal thymus in a Millipore diffusion chamber. N Engl J Med (1972) 1.37
In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing. J Immunol (1983) 1.35
Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity. J Infect Dis (1974) 1.34
Glomerular microtubules of systemic lupus erythematosus. Lancet (1970) 1.33
Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N Engl J Med (1969) 1.32
Ideal target organism for quantitative bactericidal assays. Infect Immun (1978) 1.31
Maturation of the rabbit alveolar macrophage during animal development. III. Phagocytic and bactericidal functions. Pediatr Res (1977) 1.31
Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus. J Infect Dis (1977) 1.26
Increased susceptibility of males to infection. Lancet (1969) 1.25
Development of specific cellular and humoral immune responses in children immunized with live rubella virus vaccine. J Infect Dis (1974) 1.22
Use of cryopreserved virus-infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus. Infect Immun (1976) 1.20
Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis. Infect Immun (1975) 1.18
Age-dependent susceptibility of neonatal rats to group B streptococcal type III infection: correlation of severity of infection and response of myeloid pools. Infect Immun (1982) 1.16
Biologic significance of the secretory A immunoglobulins. Pediatrics (1971) 1.16
You Can Control Asthma: evaluation of an asthma education program for hospitalized inner-city children. Patient Educ Couns (1991) 1.14
Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant. Infect Immun (1983) 1.14
Congenital anaemia after transplacental B19 parvovirus infection. Lancet (1994) 1.13
Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity. J Immunol (1975) 1.12
Herpes simplex encephalitis: virologic and serologic study of a patient treated with an interferon inducer. J Pediatr (1971) 1.08
SipA, SopA, SopB, SopD and SopE2 effector proteins of Salmonella enterica serovar Typhimurium are synthesized at late stages of infection in mice. Microbiology (2007) 1.08
Maturation of the rabbit alveolar macrophage during animal development. I. Perinatal influx into alveoli and ultrastructural differentiation. Pediatr Res (1977) 1.08
Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement. Infect Immun (1983) 1.06
Characterization of human serum and nasal hemagglutinating antibody to Francisella tularensis. J Immunol (1967) 1.05
Chemotactic and candidacidal responses of rabbit alveolar macrophages during postnatal development and the modulating roles of surfactant in these responses. Infect Immun (1984) 1.04
Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics (1975) 1.04
Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung. Eur J Respir Dis (1985) 1.03
Poly I:C induces development of diabetes mellitus in BB rat. Diabetes (1992) 1.02
Genotypic analysis of Staphylococcus aureus from milk of dairy cows with mastitis in Argentina. Epidemiol Infect (2001) 1.02
Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect Immun (1986) 1.01
Immunoglobulin responses in serum and nasal secretions after natural adenovirus infections. J Immunol (1969) 1.00
Temperature-sensitive mutants of Pseudomonas aeruginosa: isolation and preliminary immunological evaluation. Infect Immun (1982) 1.00
Antibodies to DNA in childhood systemic lupus erythematosus. J Pediatr (1971) 0.99
Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes (1992) 0.99
Chemotactic responses of various differentiational stages of neutrophils from human cord and adult blood. Infect Immun (1982) 0.98
The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model. Clin Immunol Immunopathol (1994) 0.95
Accelerated decay of glucose 6-phosphate dehydrogenase activity in chronic granulomatous disease. Pediatr Res (1970) 0.95
Enhanced liposome-mediated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro. J Microencapsul (1989) 0.95
Preliminary characterization of Pseudomonas aeruginosa peptide chemotactins for polymorphonuclear leukocytes. Infect Immun (1992) 0.93
Role of local gamma-A-immunoglobulins in immunity. Am J Dis Child (1968) 0.92
Live attenuated bacterial vaccines: new approaches for safety and efficacy. Lancet (1985) 0.92
Acute glomerulonephritis associated with normal serum B1C-globulin. Am J Dis Child (1968) 0.92
Idiopathic pulmonary hemosiderosis: ultrastructural studies and responses to azathioprine. Arch Intern Med (1976) 0.91
Lipopolysaccharide directly affects pancreatic acinar cells: implications on acute pancreatitis pathophysiology. Dig Dis Sci (2000) 0.91
Severe candidiasis associated with thymic dysplasia, IgA deficiency, and plasma antilyMPHOCYTE EFFECTS. Pediatrics (1970) 0.91
Herpes simplex encephalitis: brain biopsy and treatment with 5-iodo-2'-deoxyuridine. J Pediatr (1968) 0.91
Maturation of the rabbit alveolar macrophage during animal development. II. Biochemical and enzymatic studies. Pediatr Res (1977) 0.91
Quantitative determination of bacterial replication in vivo. Infect Immun (1985) 0.91
Impaired cellular immunity to rubella virus in congenital rubella. Infect Immun (1974) 0.90
The IgM response of children to Salmonella typhosa vaccine. I. Measurements of anti-typhoid concentrations and their proportions of total serum IgM globulins. J Immunol (1969) 0.89
Diagnostic value of IgG4 measurements in patients with food allergy. Ann Allergy (1989) 0.88
Pulmonary cell response to bacterial challenge in mutant mice with some hereditary alterations resembling cystic fibrosis. Life Sci (1980) 0.87
Comparative usefulness of ribotyping, exotoxin A genotyping, and SalI restriction fragment length polymorphism analysis for Pseudomonas aeruginosa lineage assessment. Diagn Microbiol Infect Dis (1996) 0.87
Pulmonary nonspecific defense mechanisms in cystic fibrosis. I. Phagocytic capacity of alveolar macrophages and neutrophils. Pediatr Res (1980) 0.87
Ibuprofen modifies the inflammatory response of the murine lung to Pseudomonas aeruginosa. Eur J Respir Dis (1985) 0.86
Specific inhibitory factors of cellular immunity in children with subacute sclerosing panencephalitis. J Pediatr (1976) 0.86
Immunization with temperature-sensitive mutants of Salmonella typhi induces protection in mice. Vaccine (1991) 0.85
T lymphocyte dysfunction, hyperimmunoglobulinemia E, recurrent bacterial infections, and defective neutrophil chemotaxis in a Negro child. J Pediatr (1976) 0.85
Neutrophil erythrotoxicity induced by phorbol myristate acetate: mechanisms involved in neutrophil activation. J Leukoc Biol (1991) 0.84
Enhanced liposome-mediated activity of piperacillin against staphylococci. Antimicrob Agents Chemother (1985) 0.84
Sequences related to Tn1331 associated with multiple antimicrobial resistance in different Salmonella serovars. Int J Antimicrob Agents (1995) 0.84
The emergence of resistance to amikacin in Serratia marcescens isolates from patients with nosocomial infection. Int J Antimicrob Agents (1996) 0.84
Pulmonary clearance of Staphylococcus aureus in mutant mice with some hereditary alterations resembling cystic fibrosis. Pediatr Res (1977) 0.83
Adapting a self-management education program for asthma for use in an outpatient clinic. Ann Allergy (1987) 0.83
Analysis and characterization of hematopoietic progenitor cells from fetal bone marrow, adult bone marrow, peripheral blood, and cord blood. Pediatr Res (1999) 0.83
Pseudomonas aeruginosa ribotyping: stability and interpretation of ribosomal operon restriction patterns. Diagn Microbiol Infect Dis (1996) 0.83
Factors influencing pseudomonas colonization in cystic fibrosis. Ann Allergy (1988) 0.83
Intramammary immunization with live-attenuated Staphylococcus aureus protects mice from experimental mastitis. FEMS Immunol Med Microbiol (1998) 0.83
Intramammary immunization with live-attenuated Staphylococcus aureus: microbiological and immunological studies in a mouse mastitis model. FEMS Immunol Med Microbiol (1996) 0.83
Poly I:C induction of alpha-interferon in the diabetes-prone BB and normal Wistar rats. Dose-response relationships. Diabetes (1994) 0.83
The effect of chronic intraperitoneal infusion of bacterial endotoxin on exocrine pancreas function in rats. Int J Pancreatol (1996) 0.82
Characterization of a new variant of IS257 that has displaced the capsule genes within bovine isolates of Staphylococcus aureus. Infect Immun (2007) 0.82
Molecular fingerprinting of Staphylococcus aureus isolated from patients with osteomyelitis in Argentina and clonal distribution of the cap5(8) genes and of other selected virulence genes. Eur J Clin Microbiol Infect Dis (2012) 0.82
Multicenter study on spreading of the tet(M) gene in tetracycline-resistant Streptococcus group G and C isolates in Argentina. Antimicrob Agents Chemother (2002) 0.82
Changes in superoxide dismutase, catalase and glucose-6-phosphate dehydrogenase activities of rabbit alveolar macrophages: induced by postnatal maturation and/or in vitro hyperoxia. Photochem Photobiol (1979) 0.82
Short communication. Role of agar beads in the pathogenicity of Pseudomonas aeruginosa in the rat respiratory tract. Pediatr Res (1984) 0.82